title: New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
abstract: Although multiple innovative treatments of inflammatory bowel disease have become available, research continues to refine the value of existing drug therapies for Crohn's disease and ulcerative colitis. What can Cochrane reviews tell us about evolving applications for traditional agents in inflammatory bowel disease? A Cochrane Collaboration symposium held at the 2014 Digestive Diseases Week annual meeting addressed this question. This article reviews the data presented at that session.
authors.affiliation: *Division of Gastroenterology, Department of Medicine, Western University, London, Ontario, CA; †Division of Gastroenterology, McMaster University, Hamilton, Ontario, CA; ‡Division of Gastroenterology, Departments of Medicine and Community Health Sciences, University of Calgary, Alberta, CA; §Division of Gastroenterology, University of California San Diego, La Jolla, CA; ‖Robarts Clinical Trials, Inc, Robarts Research Institute, Western University, London, Ontario, CA; Departments of ¶Medicine, and **Epidemiology and Statistics, Western University, London, Ontario, CA.
authors.forename: Nilesh
authors.initials: N
authors.lastname: Chande
authors.forename: John K
authors.initials: JK
authors.lastname: Marshall
authors.forename: Cynthia H
authors.initials: CH
authors.lastname: Seow
authors.forename: William J
authors.initials: WJ
authors.lastname: Sandborn
authors.forename: Claire E
authors.initials: CE
authors.lastname: Parker
authors.forename: Sigrid
authors.initials: S
authors.lastname: Nelson
authors.forename: Brian G
authors.initials: BG
authors.lastname: Feagan
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D019819:Budesonide / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003226:Congresses as Topic; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D060046:Maintenance Chemotherapy; D019804:Mesalamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D012196:Review Literature as Topic; D055502:Secondary Prevention
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D019804:Mesalamine; D019819:Budesonide; D001379:Azathioprine; D008727:Methotrexate